Clinical and pharmacokinetic evaluation of parenteral moxalactam in infants and children.
Thirty-four infants and children ranging in age from 2.5 to 180 months (mean, 40 months) were treated with parenteral moxalactam (150 mg/kg per day) for suspected or proved bacterial infections outside the central nervous system. Six patients infected with Haemophilus influenzae b, nine infected wit...
Na minha lista:
| Publicado no: | Antimicrob Agents Chemother |
|---|---|
| Principais autores: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society for Microbiology (ASM)
1982
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC182042/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6214210/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.21.6.898 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|